HDFC Pharma and Healthcare Fund
NAV
₹22.06
as of 21 Aug 2026
HDFC Pharma and Healthcare Fund is an open-ended Sectoral/ Thematic scheme from HDFC Mutual Fund managing ₹2,940 crore (as of 31 Jul 2026). Its Direct-plan NAV is ₹22.06 as of 21 Aug 2026. The expense ratio is 1.08% a year. Managed by Dhruv Muchhal. This page is factual data only — it carries no rating and no recommendation.
Key facts
- Expense ratio
- 1.08% / yr
- as of 30 Jun 2026
- Fund size
- ₹2,940 crore
- as of 31 Jul 2026
- Exit load
- 1%
- SIP available
- Yes
- Launched
- 4 Oct 2023
- ISIN
- INF179KC1HO1
₹100 invested, fund vs category
The category line is the average of the funds in this category, built from NYVO’s own NAV data.
Rebased to 100data to 20 Aug 2026Benchmark: Nifty 500 Healthcare TRI
HDFC Pharma and Healthcare Fund
₹222
+122% on ₹100 over 2.9 yrs
Sectoral/ Thematic average
₹182
+82% on ₹100 over 2.9 yrs
Returns vs category
| Window | Fund | Category avg | Gap |
|---|---|---|---|
| 3 months | 11.01% | – | – |
| 6 months | 22.55% | – | – |
| 1 year | 24.61% | – | – |
| 3 years (CAGR) | 31.89% | – | – |
No category average is available for this fund. Short windows are noise; the 3 and 5-year rows are the record. Past returns do not predict future returns.
A single return number depends on its start date. These are ALL the overlapping holding periods, so the worst case is visible — read that number first.
1-year holding periods
- Worst
- 1.7%
- Median
- 22.2%
- Best
- 67.0%
23 windows over the last 34 months, stepped monthly; 100% ended positive. Worst window began 1 Jan 2025. Windows overlap — this is the range of past start dates, not a probability of anything.
Distance below its own peak
Every dip below 0 is the fund trading under a previous high — how deep and for how long is what a drawdown feels like.
Right now
-1.2% below peak
Where the money actually is
Equity
99.5%
Cash
0.5%
Whole-portfolio split, as of 31 Jul 2026.
What it owns
39 positions · top 10 = 51.8%
Market-cap mix
Large 27.3%Mid 37.3%Small 34.9%Other 0.5%
as of 31 Jul 2026
Holdings by sector
Healthcare(9 in top 10)95.9%
- Sun Pharmaceuticals Industries Ltd9.66%
- Divi's Laboratories Ltd9.14%
- Max Healthcare Institute Ltd Ordinary Shares4.82%
- Aster DM Quality Care Ltd Ordinary Shares4.70%
- Lupin Ltd4.67%
- Cipla Ltd4.64%
- Alkem Laboratories Ltd3.67%
- Anthem Biosciences Ltd3.56%
- Neuland Laboratories Ltd3.40%
Basic Materials(1 in top 10)3.6%
- Acutaas Chemicals Ltd3.58%
Sectors marked ▶ expand to show this fund’s top-10 holdings in that sector. Holdings as of 31 Jul 2026. Portfolio turnover 38.2% a year.
The businesses it owns
- P/E (trailing)
- 44.8
- P/B
- 6.6
- Dividend yield
- 0.5%
- Net margin
- 16.0%
- Earnings growth
- 15.2%
- Avg market cap
- ₹62,710 crore
Money in, money out
- Net flow, 12 months
- +₹592 cr
- Net flow, 3 months
- +₹436 cr
as of 31 Jul 2026. Flows follow performance more than they predict it.
Quick answers
- What is the NAV of HDFC Pharma and Healthcare Fund?
- ₹22.06 per unit as of 21 Aug 2026 (Direct plan, growth). NAV is declared daily on working days.
- What is the expense ratio of HDFC Pharma and Healthcare Fund?
- 1.08% a year for the Direct plan, as of 30 Jun 2026.
- How large is HDFC Pharma and Healthcare Fund?
- ₹2,940 crore under management as of 31 Jul 2026, in the Sectoral/ Thematic category.
- How risky is HDFC Pharma and Healthcare Fund?
- Its SEBI Riskometer reading is "Very High Risk". One sector, one story. The most-launched shelf on the map, by far.
- Who manages HDFC Pharma and Healthcare Fund?
- Dhruv Muchhal, managing this fund for 2.8 years.
Where this fund sits
Its shelf, all funds
St · Sectoral / thematic →
One sector, one story. The most-launched shelf on the map, by far.
The money map
How big this shelf is in India →
The whole industry sized by real money, from AMFI’s monthly data.
Side by side
Compare this fund →
Put it next to any other fund — growth, returns, risk and cost in one table.
One bet or two?
Check its overlap →
See whether it owns the same stocks as your other funds.
Other Sectoral/ Thematic funds
- ICICI Prudential India Opportunities Fund₹38,299 crore
- ICICI Prudential Business Cycle Fund₹16,123 crore
- HDFC Defence Fund₹10,709 crore
- HDFC Manufacturing Fund₹10,590 crore
- SBI CONSUMPTION OPPORTUNITIES FUND₹2,959 crore
- Kotak Manufacture in India Fund₹2,951 crore
- ICICI Prudential Equity Minimum Variance Fund₹2,836 crore
- Tata India Consumer Fund₹2,815 crore
Data: NYVO research systems; each block above states its own as-of date, and blocks with no data for this fund are omitted rather than estimated. NAV updates daily on working days. The benchmark (Nifty 500 Healthcare TRI) is named for reference only; its values are licensed and never shown. This page is factual information about one scheme. It is not investment advice, not a recommendation, and it carries no rating of any kind. Past performance does not predict future returns. Mutual fund investments are subject to market risks; read all scheme related documents carefully.